<DOC>
	<DOCNO>NCT02955355</DOCNO>
	<brief_summary>The purpose study ass long-term safety , tolerability , immunogenicity subcutaneous ( SC ) treatment Immune Globulin Subcutaneous ( IGSC ) facilitate recombinant human hyaluronidase ( rHuPH20 ) ( HYQVIA/HyQvia ) participants chronic inflammatory demyelinate polyradiculoneuropathy ( CIDP ) complete Baxalta Clinical Study Protocol 161403 Epoch 1 Clinical Study Protocol 161601 without CIDP worsening .</brief_summary>
	<brief_title>Long-Term Tolerability Safety HYQVIA/HyQvia CIDP</brief_title>
	<detailed_description />
	<mesh_term>Polyradiculoneuropathy</mesh_term>
	<mesh_term>Polyradiculoneuropathy , Chronic Inflammatory Demyelinating</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<criteria>1 . Has complete Epoch 1 Study 161403 Study 161601 without CIDP worsen . 2 . If female childbearing potential , participant must negative pregnancy test baseline agree employ adequate birth control measure throughout course study . 1 . Participant serious medical condition participant 's safety medical care would impact participation Extension Study 2 . New medical condition develop participation Study 161403 Study 161601 , judgment investigator , could increase risk participant interfere evaluation investigational medicinal product ( IMP ) and/or conduct study 3 . Participant schedule participate another nonBaxalta clinical study involve IP investigational device course study 4 . The participant nursing intend begin nurse course study 5 . Participant participate another clinical study involve investigational product ( IP ) investigational device within 30 day prior enrollment ( exception Study 161403 Study 161601 ) schedule participate another clinical study involve IP investigational device course study 6 . The participant family member employee investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>